U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H23N7O
Molecular Weight 401.4643
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RISDIPLAM

SMILES

CC1=CN2N=C(C=C(C)C2=N1)C3=CC(=O)N4C=C(C=CC4=N3)N5CCNC6(CC6)C5

InChI

InChIKey=ASKZRYGFUPSJPN-UHFFFAOYSA-N
InChI=1S/C22H23N7O/c1-14-9-18(26-29-11-15(2)24-21(14)29)17-10-20(30)28-12-16(3-4-19(28)25-17)27-8-7-23-22(13-27)5-6-22/h3-4,9-12,23H,5-8,13H2,1-2H3

HIDE SMILES / InChI

Molecular Formula C22H23N7O
Molecular Weight 401.4643
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 18:06:24 GMT 2023
Edited
by admin
on Sat Dec 16 18:06:24 GMT 2023
Record UNII
76RS4S2ET1
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RISDIPLAM
INN   USAN  
Official Name English
RO-7034067
Code English
RG-7916
Code English
RO7034067
Code English
RISDIPLAM [USAN]
Common Name English
RG7916
Code English
EVRYSDI
Brand Name English
RISDIPLAM [JAN]
Common Name English
Risdiplam [WHO-DD]
Common Name English
RISDIPLAM [ORANGE BOOK]
Common Name English
RISDIPLAM [MI]
Common Name English
risdiplam [INN]
Common Name English
(7-(4,7-DIAZASPIRO(2.5)OCTAN-7-YL)-2-(2,8-DIMETHYLIMIDAZO(1,2-B)PYRIDAZIN-6-YL)PYRIDO(1,2-A)PYRIMIDIN-4-ONE
Systematic Name English
4H-PYRIDO(1,2-A)PYRIMIDIN-4-ONE, 7-(4,7-DIAZASPIRO(2.5)OCT-7-YL)-2-(2,8-DIMETHYLIMIDAZO(1,2-B)PYRIDAZIN-6-YL)-
Systematic Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/19/2145
Created by admin on Sat Dec 16 18:06:26 GMT 2023 , Edited by admin on Sat Dec 16 18:06:26 GMT 2023
FDA ORPHAN DRUG 548116
Created by admin on Sat Dec 16 18:06:26 GMT 2023 , Edited by admin on Sat Dec 16 18:06:26 GMT 2023
Code System Code Type Description
INN
10614
Created by admin on Sat Dec 16 18:06:26 GMT 2023 , Edited by admin on Sat Dec 16 18:06:26 GMT 2023
PRIMARY
CAS
1825352-65-5
Created by admin on Sat Dec 16 18:06:26 GMT 2023 , Edited by admin on Sat Dec 16 18:06:26 GMT 2023
PRIMARY
EVMPD
SUB193759
Created by admin on Sat Dec 16 18:06:26 GMT 2023 , Edited by admin on Sat Dec 16 18:06:26 GMT 2023
PRIMARY
NCI_THESAURUS
C167001
Created by admin on Sat Dec 16 18:06:26 GMT 2023 , Edited by admin on Sat Dec 16 18:06:26 GMT 2023
PRIMARY
DAILYMED
76RS4S2ET1
Created by admin on Sat Dec 16 18:06:26 GMT 2023 , Edited by admin on Sat Dec 16 18:06:26 GMT 2023
PRIMARY
RXCUI
2390935
Created by admin on Sat Dec 16 18:06:26 GMT 2023 , Edited by admin on Sat Dec 16 18:06:26 GMT 2023
PRIMARY
DRUG BANK
DB15305
Created by admin on Sat Dec 16 18:06:26 GMT 2023 , Edited by admin on Sat Dec 16 18:06:26 GMT 2023
PRIMARY
USAN
FG-179
Created by admin on Sat Dec 16 18:06:26 GMT 2023 , Edited by admin on Sat Dec 16 18:06:26 GMT 2023
PRIMARY
FDA UNII
76RS4S2ET1
Created by admin on Sat Dec 16 18:06:26 GMT 2023 , Edited by admin on Sat Dec 16 18:06:26 GMT 2023
PRIMARY
SMS_ID
100000178153
Created by admin on Sat Dec 16 18:06:26 GMT 2023 , Edited by admin on Sat Dec 16 18:06:26 GMT 2023
PRIMARY
WIKIPEDIA
Risdiplam
Created by admin on Sat Dec 16 18:06:26 GMT 2023 , Edited by admin on Sat Dec 16 18:06:26 GMT 2023
PRIMARY
PUBCHEM
118513932
Created by admin on Sat Dec 16 18:06:26 GMT 2023 , Edited by admin on Sat Dec 16 18:06:26 GMT 2023
PRIMARY
MERCK INDEX
m12240
Created by admin on Sat Dec 16 18:06:26 GMT 2023 , Edited by admin on Sat Dec 16 18:06:26 GMT 2023
PRIMARY
EPA CompTox
DTXSID701109185
Created by admin on Sat Dec 16 18:06:26 GMT 2023 , Edited by admin on Sat Dec 16 18:06:26 GMT 2023
PRIMARY
Related Record Type Details
METABOLIC ENZYME -> SUBSTRATE
MAJOR
TRANSPORTER -> INHIBITOR
IN VITRO
TRANSPORTER -> SUBSTRATE
IN VITRO
WEAK
EXCRETED UNCHANGED
FECAL
METABOLIC ENZYME -> SUBSTRATE
TRANSPORTER -> SUBSTRATE
IN VITRO
WEAK
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
TRANSPORTER -> INHIBITOR
IN VITRO
METABOLIC ENZYME -> SUBSTRATE
MAJOR
EXCRETED UNCHANGED
URINE
OFF TARGET->NON-INHIBITOR
IC50
METABOLIC ENZYME -> SUBSTRATE
TARGET -> INDUCER
SMN2 Gene Splicing Modifier for the treatment of Spinal Muscular Atrophy (SMA)
EC50
Related Record Type Details
METABOLITE INACTIVE -> PARENT
MAJOR
PLASMA
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
Tmax PHARMACOKINETIC ORAL ADMINISTRATION

Volume of Distribution PHARMACOKINETIC AT STEADY-STATE